首页 › 基金 › Squadron Capital Management LLC › CUE
Squadron Capital Management LLC 对 CUE 的持仓历史
CUE BIOPHARMA · 医疗保健
Squadron Capital Management LLC 在 Q2 2026 的 13F 申报中披露持有 CUE(CUE BIOPHARMA)50,000 股,市值约 US$1.6M,约占其申报组合的 0.62%,在其申报持仓中市值排名第 31 位。 Squadron Capital Management LLC 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Squadron Capital Management LLC 对 CUE 的持仓演变
Squadron Capital Management LLC 于 Q2 2026 首次披露 CUE 持仓:50,000 股(约 US$1.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 50.00K | $1.58M | 新进 |
关于 CUE 与 13F 数据
CUE(CUE BIOPHARMA)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 CUE,申报仓位最大的包括:Bleichroeder LP (US$11.7M), Tetragon Partners GP Ltd (US$3.0M), Lion Point Capital, LP (US$1.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CUE 的基金
- Bleichroeder LP 370.68K 股 · $11.70M · Q2 2026
- Tetragon Partners GP Ltd 93.82K 股 · $2.96M · Q2 2026
- Lion Point Capital, LP 52.93K 股 · $1.67M · Q2 2026
更多关于 Squadron Capital Management LLC
常见问题
How long has Squadron Capital Management LLC held CUE?
Squadron Capital Management LLC has disclosed CUE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Squadron Capital Management LLC's current position in CUE?
As of Q2 2026, Squadron Capital Management LLC holds 50.00K shares of CUE (CUE BIOPHARMA), valued at $1.58M, representing 0.62% of its reported portfolio and ranking #31.
Has Squadron Capital Management LLC been buying or selling CUE?
In the latest 13F filing (Q2 2026), Squadron Capital Management LLC newly opened its position in CUE.
Which other funds hold CUE?
Other major institutional holders of CUE include Bleichroeder LP, Tetragon Partners GP Ltd, Lion Point Capital, LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.